Delivery Order SPE2DB20D1004-SPE2DB21FG0S9

Award Date 9/15/21
Potential Completion Date 9/16/21
Potential Value $1.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Methylphenidate ER 54 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $3,094.85 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
This federal contract award is for the delivery of Methylphenidate ER 54 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $2,189.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a performance period ending on February 29, 2024. The award is not designated under any set-aside program, indicating it was competitively awarded. Amerisourcebergen...
This federal contract award is for the delivery of Methylphenidate ER 54 mg Tablets in 100-count bottles, valued at $3,749.43. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to support military healthcare programs. This appears to be a delivery order under a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets in 100-count packages. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) on March 19, 2025. The contract has a ceiling value of $1,056.00 and a completion date of March 20, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 12, 2024 with a ceiling value of $2,196.76 and a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of 100 tablets of Methylphenidate ER 54 mg to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $2,559.46. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 1, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets in quantities of 100. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $8,804.66 and has a completion date of June 20, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of 4,566,810,759 tablets of Methylphenidate ER 36 mg, a prescription medication, to the Defense Logistics Agency (DLA). The $1,646.73 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024, with a completion date of December 31, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets in quantities of 100s to the Defense Logistics Agency (DLA). The $3,188.30 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This order is a child of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The single-award contract, valued at up to $3,305.84, was granted to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has a firm-fixed price pricing type and a period of performance ending on July 2, 2024. It is not designated as a set-aside contract....
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB21FG0S9
    Delivery Order

This federal contract award is for the delivery of Methylphenidate ER 54 mg tablets to the Defense Logistics Agency (DLA), a combat support agency of the U.S. Department of Defense. The contract, valued at $1,794.61, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 15, 2021. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA in support of military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:09 AM